PB1956: EVALUATION OF AN INNOVATIVE NEW METHOD FOR QUANTITATION OF PLASMA CELLS ON CD138 IMMUNOHISTOCHEMISTRY

PB1956: EVALUATION OF AN INNOVATIVE NEW METHOD FOR QUANTITATION OF PLASMA CELLS ON CD138 IMMUNOHISTOCHEMISTRY

Bibliographic Details
Main Authors:	E. Gantana, N. Mashigo, I. Abdullah, E. Musekwa, R. Lohlun, E.-M. Nell, C. Chetty, M. Ntobongwana, Z. Chapanduka
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850660.08752.99

Similar Items

Indications and diagnostic value of bone marrow examination in HIV-positive individuals: A 3-year review at Tygerberg Hospital
by: Ibtisam Abdullah, et al.
Published: (2021-08-01)

CD138 immunohistochemistry identifies more plasma cells compared with hematoxylin and eosin staining in autoimmune hepatitis. An observational study
by: A.F. Romano-Munive, et al.
Published: (2024-01-01)

Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice
by: David K. Meyerholz, et al.
Published: (2022-06-01)

Factors associated with bone marrow involvement in lymphoma staging bone marrow examination: A South African single-centre retrospective study
by: Robert K. Lohlun, et al.
Published: (2022-08-01)

PB2036: PERIPHERAL BLOOD CYTOPENIA, AN EARLY INDICATOR OF INBORN ERRORS OF IMMUNITY
by: Zivanai Cuthbert Chapanduka, et al.
Published: (2023-08-01)

Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma
by: Sabna Rajeev Krishnan, et al.
Published: (2016-01-01)

Study on expression of plasma sCD138 in patients with hemorrhagic fever with renal syndrome
by: Jing Li, et al.
Published: (2018-03-01)

Syndecan-1 (CD138), Carcinomas and EMT
by: John R. Couchman
Published: (2021-04-01)

In-depth investigation of turn-around time of full blood count tests requested from a clinical haematology outpatient department in Cape Town, South Africa
by: Leonard Mutema, et al.
Published: (2021-04-01)

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.
by: Zihni Onur Çalışkaner, et al.
Published: (2017-01-01)

Deep Learning Accurately Quantifies Plasma Cell Percentages on CD138-Stained Bone Marrow Samples
by: Fred Fu, et al.
Published: (2022-01-01)

An 8-year retrospective study of adult and paediatric Burkitt’s lymphoma at Tygerberg Hospital, South Africa
by: Ernest Musekwa, et al.
Published: (2020-04-01)

PB2077: COMPARISON OF PLASMA CELL PERCENTAGE BY BONE MARROW ASPIRATE MORPHOLOGY AND CD138-STAINED BONE MARROW BIOPSY IN SMOLDERING MYELOMA TO PREDICT TRANSFORMATION TO SYMPTOMATIC MYELOMA
by: Helen Cashman, et al.
Published: (2023-08-01)

Thrombophagocytosis by neutrophils as a spurious cause of thrombocytopenia
by: Erica‐Mari Nell, et al.
Published: (2021-08-01)

Quantitative immunohistochemistry in lung cancer: clinical perspective.
by: Rafał Dziadziuszko, et al.
Published: (2010-06-01)

Galactic production of 138La: Impact of 138,139La statistical properties
by: B.V. Kheswa, et al.
Published: (2015-05-01)

Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device
by: Menachery, Anoop, et al.
Published: (2017)

CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study
by: Mousa A Al-Abbadi, et al.
Published: (2016-07-01)

Comparison of the IHC markers CD138 and CD43 in oral leukoplakia: An original research
by: Anitha Akkaloori, et al.
Published: (2023-01-01)

A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells
by: David J Turner, et al.
Published: (2022-04-01)

Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cells.
by: Farizeh Aalam, et al.
Published: (2020-10-01)

Disease associations and altered immune function in CD45 138G variant carriers.
by: Boxall, S, et al.
Published: (2004)

L138 F690 (138) [fotograf udara]

Geographical distribution and disease associations of the CD45 exon 6 138G variant.
by: Ward, V, et al.
Published: (2006)

Targeted therapy for multiple myeloma: an overview on CD138-based strategies
by: Federico Riccardi, et al.
Published: (2024-04-01)

THE NEW DIAGNOSTIC FEATURES OF CD138 (SYNDECAN-1) IN MULTIPLE MYELOMA
by: A. F. Karamysheva
Published: (2015-12-01)

Comparison of Choi and Hans' algorithms by immunohistochemistry and quantitative reverse transcriptase-PCR - letter.
by: Ballabio, E, et al.
Published: (2010)

Editorial 138
by: Miryam Colacrai, et al.
Published: (2023-12-01)

A138
by: K. Yurchenko, et al.
Published: (2015-11-01)

Presentación No. 138
by: El Editor
Published: (2017-02-01)

Aetiology of pancytopenia: Experience of a South African tertiary academic centre
by: Erica-Mari Nell, et al.
Published: (2022-05-01)

L138 F690 (138-150) [fotograf udara]

L138 F690 (138-150) [fotograf udara]

PB2341: MIDAZOLAM AND LOCAL ANAESTHESIA CO-ADMINISTRATION GIVES BETTER PAIN CONTROL DURING THE BONE MARROW ASPIRATION AND BIOPSY PROCEDURE
by: Z. C. Chapanduka
Published: (2022-06-01)

The role of CD10 immunohistochemistry in the grading of phyllodes tumour of the breast
by: Hussin, Huzlinda, et al.
Published: (2013)

1159 A targeted masked ImmunoCytokine for CD138 expressing cancers
by: Ryan Trinh, et al.
Published: (2023-11-01)

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
by: Margaret Yeh, et al.
Published: (2021-04-01)

An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138<sup>+</sup> cells
by: Nakayama Shoko, et al.
Published: (2012-09-01)

Immunohistochemistry
by: G Aryal
Published: (2015-09-01)

The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
by: Jain, R, et al.
Published: (2010)